News
Foreign Office on Friday urged the international community to adopt non-discriminatory policies to address terrorism, ...
ISLAMABAD: Pakistan on Friday called on the international community to classify the Majeed Brigade as an alias of the banned ...
Pakistan, having made unparalleled sacrifices in the global counter-terrorism arena, urged the international community to ...
2h
Zacks Investment Research on MSNRegeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock ...
George Mulligan, PhD, previews the FDA's ODAC meeting discussing the application of belantamab mafodotin-based combinations for the treatment of multiple myeloma.
A New York-based privately held real estate operator and investment management firm has purchased the Park Place student ...
Explore more
The Baloch Liberation Army (BLA) has claimed responsibility for two attacks in Balochistan, killing 29 Pakistani soldiers. In ...
1d
ABP News on MSNBalochistan Liberation Army Attack Kills 29 Pakistani Soldiers In Major Strike On Quetta And KalatIn a major development, the Balochistan Liberation Army (BLA) has launched a deadly attack on Pakistani military forces, ...
Balochistan's security situation took a dramatic turn this week, as both banned separatist groups, Balochistan Liberation ...
Police and government officials in southwestern Pakistan say that gunmen have opened fire on a passenger bus, killing at least three people and wounding seven others ...
The U.S. FDA has accepted a Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi (golimumab).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results